Abstract
The function of the alpha-2-receptor and intracellular effector systems was examined in 39 panic disorder patients and 30 healthy subjects using the platelet as a model system. Alpha-2-receptor density, as reflected by 3H-yohimbine binding, was not different between the two groups. Platelet alpha-2-receptor affinity was decreased (higher K d) in the panic disorder patients. Other significant abnormalities in the patients included a decreased basal adenylate cyclase activity, reduced EC50 for the epinephrine inhibition of adenylate cyclase activity, and decreased stimulation of adenylate cyclase activity by prostaglandin E1 and sodium fluoride. These results are consistent with a dysfunction in some panic disorder patients at the level of the stimulatory GTP binding regulatory protein, Gs, or the adenylate cyclase catalytic unit. The relationship of these findings to previous studies of noradrenergic function in panic disorder patients is discussed.
Similar content being viewed by others
References
Aktories K, Jacobs KH (1982) Epinephrine inhibits adenylate cyclase and stimulates a GTPasc in human platelet membranes via alpha-adrenoceptors. FEBS Lett 130:235–240
Cameron OG, Smith CB, Hollingsworth PJ, Nesse RM, Curtis GC (1984) Platelet α2-adrenergic receptor binding and plasma catecholamines: before and during imipramine treatment in patients with panic anxiety. Arch Gen Psychiatry 41:1144–1148
Charney DS, Heninger GR (1986) Abnormal regulation of noradrenergic function in panic disorders: effects of clonidine in healthy subjects and patients with agoraphobia and panic disorder. Arch Gen Psychiatry 43:1042–1054
Charney DS, Heninger GR, Breier A (1984) Noradrenergic function in panic anxiety: effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder. Arch Gen Psychiatry 41:751–763
Charney DS, Woods SW, Goodman WK, Heninger GR (1987) Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks. Am J Psychiatry 144:1030–1036
Charney DS, Woods SW, Heninger GR (1988) Noradrenergic function in generalized anxiety disorder: effects of yohimbine in healthy subjects and patients with generalized anxiety disorder. Psychiatr Res (in press)
Egan B, Neubig R, Julius S (1985) Pharmacologic reduction of sympathetic drive increases platelet alpha-2-receptor number. Clin Pharmacol Ther 38:519–524
Garver DL, Johnson C, Kanter DR (1982) Schizophrenia and reduced cyclic AMP production: evidence for the role of receptor-linked events. Life Sci 31:1987–1992
Gilman AG (1984) G Proteins and dual control of adenylate cyclase. Cell 36:577–579
Glazer WM, Charney DS, Heninger GR (1987) Noradrenergic function in schizophrenia. Arch Gen Psychiatry 44:898–904
Hamilton CA, Reid JL (1986) Platelet α-adrenoceptors — a valid model for brain or vascular adrenoceptors? Br J Clin Pharmacol 22:623–626
Hamilton CA, Jones CR, Mishra N, Barr S, Reid JL (1985) A comparison of α2-adrenoceptor regulation in brain and platelets. Brain Res 347:350–353
Heninger GR, Charney DS, Price LH (1988) Alpha-2-adrenergic receptor sensitivity in depression: the plasma MHPG, behavioral, and cardiovascular responses to yohimbine. Arch Gen Psychiatry 45:718–726
Hoffman BB, Michel T, Brenneman TB, Lefkowitz RJ (1982) Interactions of agonists with platelet α2-adrenergic receptors. Endocrinology 110:926–932
Jakobs KH, Saur W, Schultz G (1976) Reduction of adenylate cyclase activity in lysates of human platelets by the alpha-adrenergic component of epinephrine. J Cyclic Nucleotide Res 2:381–392
Kafka MS, van Kammen DP (1983) Alpha-adrenergic receptor function in schizophrenia. Arch Gen Psychiatry 40:264–270
Kafka MS, Paul SM (1986) Platelet α2-adrenergic receptors in depression. Arch Gen Psychiatry 43:91–95
Kafka MS, van Kammen DP, Bunney WE (1979) Reduced cyclic AMP production in the blood platelets from schizophrenic patients. Am J Psychiatry 136:685–687
Kafka MS, van Kammen DP, Kleinman JE, Nurnberger JI, Siever LJ, Uhde TW, Polinsky RJ (1980) Alpha-adrenergic receptor function in schizophrenia, affective disorders, and some neurological diseases. Commun Psychopharmacol 4:477–486
Kanof PD, Johns C, Davidson M, Siever LJ, Coccaro EF, Davis KL (1986) Prostaglandin receptor sensitivity in psychiatric disorders. Arch Gen Psychiatry 43:987–993
Lerer B, Ebstein RP, Shestatsky M, Shemesh Z, Greenberg D (1987) Cyclic AMP signal transduction in posttraumatic stress disorder. Am J Psychiatry 144:1324–1327
Mooney JJ, Schatzberg AF, Cole JO, Kizuka PP, Salomon M, Lerbinger J, Pappalardo KM, Gerson B, Schildkraut JJ (1988) Rapid antidepressant response to alprazolam in depressed patients with high catecholamine output and heterologous desensitization of platelet adenylate cyclase. Biol Psychiatry 23:543–559
Motulsky HJ, Shattil SJ, Insel PA (1980) Characterization of alpha2 adrenergic receptors on human platelets using [3H]yohimbine. Biochem Biophys Res Commun 97:1562–1570
Murphy DL, Donnelly C, Moskowitz J (1974) Catecholamine receptor function in depressed patients. Am J Psychiatry 131:1389–1391
Norman TR, Kimber NM, Judd FK, Burrows GD, McIntyre LM (1987) Platelet 3H-rauwolscine binding in patients with panic attacks. Psychiatr Res, 22:43–48
Nutt DJ (1988) Altered central alpha-2 adrenoceptor sensitivity in panic disorder. Arch Gen Psychiatry (in press)
Nutt DJ, Fraser S (1987) Platelet binding studies in panic disorder. J Affect Disord 12:7–11
Pandey GN, Garver DL, Tamminga C, Ericksen S, Ali SI, Davis JM (1977) Postsynaptic supersensitivity in schizophrenia. Am J Psychiatry 134:518–522
Partington CR, Edwards MW, Daly JW (1980) Regulation of cyclic AMP formation in brain tissues by alpha-adrenergic receptors: requisite intermediacy of prostaglandins of the E series. Proc Natl Acad Sci USA 77:3024–3028
Pfeifer MA, Ward K, Malpass T, Stratton J, Halter J, Evans M, Beiter H, Harker LA, Porte D Jr (1984) Variations in circulating catecholamines fail to alter human platelet alpha-2-adrenergic receptor number or affinity for [3H]yohimbine or [3H]dihydroergocryptine. J Clin Invest 74:1063–1072
Price LH, Charney DS, Rubin AL, Heninger GR (1986) Alpha-2 adrenergic receptor function in depression: the cortisol response to yohimbine. Arch Gen Psychiatry 43:849–858
Rasmussen SA, Goodman WK, Woods SW, Heninger GR, Charney DS (1987) Effects of yohimbine in obsessive compulsive disorder. Psychopharmacology 93:308–313
Redmond DE Jr, Huang YH (1979) New evidence for a locus coeruleus-norepinephrine connection with anxiety. Life Sci 25:2149–2162
Rodbell M (1980) The role of hormone receptors and GTP-regulatory proteins in membrane transduction. Nature 284:17–22
Rotrosen J, Miller AD, Mandio D, Traficante LJ, Gershon S (1980) Prostaglandins, platelets, and schizophrenia. Arch Gen Psychiatry 37:1047–1054
Salomon Y, Londos C, Rodbell M (1974) A highly sensitive adenylate cyclase assay. Anal Biochem 58:541–548
Siever LJ, Kafka MS, Targum S, Lake CR (1984) Platelet alphaadrenergic binding and biochemical responsiveness in depressed patients and controls. Psychiatr Res 11:287–302
Snavely MD, Motulsky HJ, O'Connor DT, Ziegler MG, Insel PA (1982) Adrenergic receptors in human and experimental pheochromocytoma. Clin Exp Hypertens 5:829–848
Steer ML, Wood A (1979) Regulation of human platelet adenylate cyclase by epinephrine, prostaglandin E1 and guanine nucleotides: evidence for separate guanine nucleotide sites mediating stimulation and inhibition. J Biol Chem 254:10791–10797
Sternweis PC, Gilman AG (1982) Aluminium: a requirement for activation of the regulatory component of adenylate cyclase by fluoride Proc Natl Acad Sci USA 79:4888–4891
Tabakoff BT, Hoffman PL, Lee JM, Saito T, Willard B, De Leon-Jones F (1988) Differences in platelet enzyme activity between alcoholics and nonalcoholics. N Engl J Med 318:134–139
Uhde TW, Boulinger JP, Post RM (1984) Fear and anxiety: relationship to noradrenergic function. Psychopathology 17(3):8–23
Wang YC, Pandey GN, Mendels J, Frazer A (1974) Platelet adenylate cyclase responses in depression: implications for a receptor defect. Psychopharmacology 36:291–300
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Charney, D.S., Innis, R.B., Duman, R.S. et al. Platelet alpha-2-receptor binding and adenylate cyclase activity in panic disorder. Psychopharmacology 98, 102–107 (1989). https://doi.org/10.1007/BF00442014
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00442014